What's New?

Recent Publications

• 2011 ARCH Research Report
• Antenatal Magnesium Sulphate prior to preterm birth for neuroprotection of the fetus, infant and child - National Clinical Practice Guidelines - updated November 2010 with NHMRC approval
• Consumer Information Brochure - Magnesium Sulphate prior to Preterm Birth

Trials

• MAGENTA: Magnesium sulphate at 30 to 34 weeks' gestational Age: Neuroprotection Trial
• WISH: Working to Improve Survival and Health for Babies Born Very Preterm

Individual Participant Data meta-analysis

• AMICABLE: Antenatal Magnesium IPD International Collaboration: assessing the benefits for babies using the best level of evidence
• PRECISE: Prenatal REpeat Corticosteroid International IPD Study Group: assessing the effects using the best level of Evidence Study